Dr. Cortese is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
CSC P852
Elm and Carlton Streets
Buffalo, NY 14263Phone+1 716-845-2326Fax+1 716-845-3894
Summary
- Dr. Matthew Cortese, based in Buffalo, NY, is an accomplished professional in the field of Oncology, with subspecialties in Cancer Genetics/Cancer Risk Assessment, Hematologic Oncology, and Clinical Informatics. His educational background includes significant achievements in the Residency and Fellowship programs of the renowned University of Cincinnati Medical Center/College of Medicine and Cleveland Clinic Foundation respectively. He also holds a Master’s degree in Public Health from Syracuse University & SUNY Upstate Medical University, demonstrating a commitment to comprehensive patient care. His specialization includes treatment and research on non-hodgkin lymphoma, chemotherapy, immunotherapy, chronic lymphoid leukemia, and b-cell lymphomas. He has made considerable contributions to oncological literature and has participated in clinical trials related to chronic lymphocytic leukemia and hematologic malignancies.
Education & Training
Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 2019 - 2022
University of Cincinnati Medical Center/College of MedicineResidency, Internal Medicine, 2016 - 2019
SUNY Upstate Medical UniversityClass of 2016
Syracuse University & SUNY Upstate Medical UniversityMaster of Public Health, Public Health Practice & Administration, 4.0 GPA, 2011 - 2016- Cornell UniversityBS, Biological Sciences, Ecology & Evolutionary Biology concentration, Cum Laude, Distinction in Research, 2005 - 2009
- Homer Senior Central High SchoolHigh School, Advanced Regents with Honors, AP Scholar with Honors, US Army Reserve Scholar, 2001 - 2005
Certifications & Licensure
NY State Medical License 2022 - 2027
OH State Medical License 2021 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Certificate of Excellence for collegiality, professionalism, and patient safety Roswell Park Comprehensive Cancer Center, Peer Review Leadership Committee, 2024
Clinical Trials
- A Study of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Start of enrollment: 2022 Sep 12
- Autologous CD19 CAR-T Cell Therapy (SYNCAR-001) + Orthogonal IL-2 (STK-009) in Subjects With CD19+ Hematologic Malignancies Start of enrollment: 2022 Jun 24
- A Phase 1 Study of ADI-001 in B Cell Malignancies Start of enrollment: 2021 Mar 04
Roles: Contact
Publications & Presentations
PubMed
- 4 citationsSubsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy.Megan Melody, Narendranath Epperla, Geoffrey Shouse, Jason Romancik, Pamela Allen
Blood Advances. 2024-05-28 - 6 citationsChronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in OncologyWilliam G Wierda, Jennifer Brown, Jeremy S Abramson, Farrukh Awan, Syed F Bilgrami
Journal of the National Comprehensive Cancer Network. 2024-04-01 - 1 citationsImpact of active surveillance at time of diagnosis on overall survival in nodular lymphocyte-predominant Hodgkin lymphoma: A National Cancer Database study.Victoria M Rogness, Wei Wei, Matthew Cortese, Brian T Hill
Leukemia Research. 2023-11-01
Press Mentions
Tandem 2025: Roswell Park Team Creates Predictive Model to Inform Care of Lymphoma PatientsFebruary 3rd, 2025- Roswell Park Experts Report Insights on CAR T for Follicular Lymphoma, KEYNOTE-667 Combo in Hodgkin LymphomaDecember 8th, 2024
- Roswell Park Study Reveals How Venetoclax Boosts Immune Response to CAR T for Chronic Lymphocytic LeukemiaDecember 7th, 2024
- Join now to see all
Committees
- Ad hoc Member, Provider Informatics Leadership Team (PILT) 2022 - Present
- Member, Data and Safety Monitoring Committee (DSMC) 2022 - Present
Professional Memberships
- Member
- Member
- Member
- American Society for Transplantation and Cellular TherapyMember
External Links
- RPCI Faculty Profilehttps://www.roswellpark.org/matthew-cortese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
